AT, E., D, K., WC, M., J, F., CB, H., LS, M., . . . KE, L. (2024). Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm reduction journal, 21(1), 214. https://doi.org/10.1186/s12954-024-01131-6
Chicago Style (17th ed.) CitationAT, Estadt, et al. "Differences in Hepatitis C Virus (HCV) Testing and Treatment by Opioid, Stimulant, and Polysubstance Use Among People Who Use Drugs in Rural U.S. Communities." Harm Reduction Journal 21, no. 1 (2024): 214. https://doi.org/10.1186/s12954-024-01131-6.
MLA (9th ed.) CitationAT, Estadt, et al. "Differences in Hepatitis C Virus (HCV) Testing and Treatment by Opioid, Stimulant, and Polysubstance Use Among People Who Use Drugs in Rural U.S. Communities." Harm Reduction Journal, vol. 21, no. 1, 2024, p. 214, https://doi.org/10.1186/s12954-024-01131-6.